anll developed in 16 of the 77 remaining untreated patients , including 18 % ( 2/11 ) , 0 % ( 0/21 ) , 22 % ( 5/23 ) , 33 % ( 2/6 ) , and 44 % ( 7/16 ) of patients with refractory anemia ( ra ) , refractory anemia with ring sideroblasts ( rars ) , raeb , cmml , and raeb/tr , respectively ( p = 0.02 ) .
C0002893
refractory anemia
C0002894
raeb/tr